ScholarLens Back to search
2010•Zhongguo redai yixueRequires access

Effect of mosapride citrate tablets on 115 gastroesphageal reflux disease cases

Wang Qi-qua

Open publisher page 0 citations

Abstract

Aim To observe the effect and recrudesce of Mosapride citrate tablets on refractory gastroesophageal reflux disease.Methods There 115 of outpatients and inpatients cases with gastroesophageal reflux disease were randomly divided into treatment group(65 cases)treated with mosapride citrate tablets,rabeprazol combined with sucralfate tablets,and control groups(50 cases) treated with domperidone,rabeprazo combined with sucralfate tablets for 6 weeks.Results After treatment the total effective rates recurrent rates in the treatment groups were 95.3% and 11.0%,while that in the control group were 84.0% and 23.0%,all showing significant difference between the two groups(P0.05).Conclusion Mosapride citrate tablet is effective on refractory gastroesophageal reflux disease without adverse reaction.

About this research paper

What this paper is about

Aim To observe the effect and recrudesce of Mosapride citrate tablets on refractory gastroesophageal reflux disease.Methods There 115 of outpatients and inpatients cases with gastroesophageal reflux disease were randomly divided into treatment group(65 cases)treated with mosapride citrate tablets,rabeprazol combined with sucralfate tablets,and control groups(50 cases) treated with domperidone,rabeprazo combined with sucralfate tablets for 6 weeks.Results After treatment the total effective rates recurrent rates in the treatment groups were 95.3% and 11.0%,while that in the control group were 84.0% and 23.0%,all showing significant difference between the two groups(P0.05).Conclusion Mosapride citrate tablet is effective on refractory gastroesophageal reflux disease without adverse reaction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To observe the effect and recrudesce of Mosapride citrate tablets on refractory gastroesophageal reflux disease.Methods There 115 of outpatients and inpatients cases with gastroesophageal reflux disease were randomly divided into treatment group(65 cases)treated with mosapride citrate tablets,rabeprazol combined with sucralfate tablets,and control groups(50 cases) treated with domperidone,rabeprazo combined with sucralfate tablets for 6 weeks.Results After treatment the total effective rates recurrent rates in the treatment groups were 95.3% and 11.0%,while that in the control group were 84.0% and 23.0%,all showing significant difference between the two groups(P0.05).Conclusion Mosapride citrate tablet is effective on refractory gastroesophageal reflux disease without adverse reaction.

Key concepts: Sucralfate, Domperidone, Mosapride, Reflux, Medicine, Gastroenterology, Internal medicine, Refractory (planetary science)

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effect of mosapride citrate tablets on 115 gastroesphageal reflux disease cases — Research Paper | ScholarLens